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Abstract
Purpose To investigate the global transcriptome and associated embryonic molecular networks impactedwith advancedmaternal
age (AMA).
Methods Blastocysts derived from donor oocyte IVF cycles with no male factor infertility (< 30 years of age) and AMA
blastocysts (≥ 42 years) with no other significant female factor infertility or male factor infertility were collected with informed
patient consent. RNA sequencing libraries were prepared using the SMARTer® Ultra® Low Kit (Clontech Laboratories) and
sequenced on the Illumina HiSEQ 4000. Bioinformatics included Ingenuity® Pathway Analysis (Qiagen) with ViiA™ 7 qPCR
utilized for gene expression validation (Applied Biosystems).
Results A total of 2688 significant differentially expressed transcripts were identified to distinguish the AMA blastocysts from
young, donor controls. 2551 (95%) of these displayed decreased transcription in the blastocysts from older women. Pathway
analysis revealed three altered molecular signaling networks known to be critical for embryo and fetal development: CREBBP,
ESR1, and SP1. Validation of genes within these networks confirmed the global decreased transcription observed in AMA
blastocysts (P < 0.05).
Conclusions A significant, overall decreased global transcriptome was observed in blastocysts from AMA women. The
ESR1/SP1/CREBBP pathway, in particular, was found to be a highly significant upstream regulator impacting biological
processes that are vital during embryonic patterning and pre-implantation development. These results provide evidence that
AMA embryos are compromised on a cell signaling level which can repress the embryo’s ability to proliferate and implant,
contributing to a deterioration of reproductive outcomes.
Keywords Advancedmaternal age . Human blastocyst . Transcriptome . Gene expression
Introduction
The effects of female aging on fertility are well described and
impact, among others, ovarian reserve, oocyte quality, and
pregnancy complications [1]. Chromosome aneuploidy is a
significant contributor to infertility, with maternal age being
the greatest risk factor [2]. Meiotic events occurring during
oogenesis, particularly the prolonged arrest in dictyate, in-
crease the susceptibility of chromosome segregation errors
and this is observed in the oocytes from older women [3].
The association between increasing maternal age and the fre-
quency of chromosome aneuploidy in human conception, in-
cluding Down’s syndrome, has been extensively documented
[4]. This leads to an increased risk of spontaneous abortion as
women age, with more than half of all pregnancies resulting in
a fetal loss by the time a woman reaches 42 years of age [5]. In
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fact, 75% of spontaneous miscarriages in women 35 years and
older are the direct result of chromosome anomalies, com-
pared to 50% in mothers younger than 35 years of age [6].
Infertile women of advanced maternal age (AMA) can utilize
assisted reproductive technologies (ART) and pre-
implantation genetic testing for aneuploidy (PGT-A) to selec-
tively transfer euploid embryos with successful clinical out-
comes. Nevertheless, these women do see a decrease in live
birth rates compared to their younger counterparts, indicating
a reduced implantation potential independent of chromosome
constitution.
Oogenesis is a process that involves a complex series of
nuclear and cytoplasmic events that prepare the oocyte for
fertilization and initiate pre-implantation embryo develop-
ment until the activation of the embryonic genome [7, 8].
The quality of the oocyte will determine an embryo’s devel-
opmental potential and an aged oocyte can have dysfunctions
in the cellular organelles including, among others, the endo-
plasmic reticulum and mitochondria which play a role in Ca2+
storage and absorption, culminating in apoptosis [9–11]. This
storage and redistribution of calcium by the endoplasmic re-
ticulum is responsible for cell activation during fertilization
and can affect embryo development and implantation [12].
Mitochondria are essential for oocyte maturation, fertilization,
and development since they act as the major source of ATP
during pre-implantation embryonic development [13].
Damage to mitochondria can also cause increased production
of reactive oxygen species (ROS), via oxidative phosphoryla-
tion during ATP production, and accumulate over time to ex-
pose the aged oocyte to oxidative stress [14]. Taken together,
this can promote the aging process by negatively influencing
cell signaling pathways that are involved in proliferation, dif-
ferentiation, and apoptosis which then result in DNA damage
or developmental arrest [15, 16].
Aging can also impact epigenetic factors, specifically his-
tone modifications, which are essential for oocyte develop-
ment [17]. There are several forms of modifications at the
histone amino termini including methylation, acetylation,
phosphorylation, and ubiquitination, all of which play impor-
tant roles in cell cycle progression, DNA replication and re-
pair, and transcriptional activity [18–20]. Histone acetylation
in particular is critical for these cellular functions, as well as
regulating chromosome segregation and various chromatin-
based processes [21]. In mammalian oocytes, histones are
deacetylated by histone deacetylase (HDAC) genes during
meiosis and inhibitions to HDAC activity have been reported
to induce aneuploidy and early embryonic death in mice [21,
22].
There is currently limited knowledge of how advanced
maternal aging impacts the developmental competence of an
embryo on a molecular level. More recently, a study looked at
the effects of parental age on downstream gene expression in
human blastocysts and found that maternal age had a
significant impact on changes in the blastocyst transcriptome
with more than 800 genes having reduced expression as ma-
ternal age increased (ranging from 31 to 41 years of age) [23].
Among these downregulated genes, several were considered
to be important for meiotic chromosomal segregation, cell
cycle control, and embryo growth and implantation.
The aim of our study was to elucidate the cellular tran-
scriptome of human blastocysts from women of considerable
advancedmaternal age (≥ 42 years), to further our understand-
ing of oocyte aging and its impact on embryonic competence
and reproductive success. This knowledge will provide a valu-
able molecular explanation, independent of chromosome con-




Surplus, cryopreserved, transferrable quality (grade ≥ 3BB)
human blastocysts were fertilized using intracytoplasmic
sperm injection and sequentially cultured under low oxygen
conditions prior to being donated to research with Institutional
Review Board approval and patient consent: young, oocyte
donor control with no male factor infertility (DC < 30 years;
n = 12 from 6 different patients), and advanced maternal age
with nomale factor or other significant female factor infertility
(AMA ≥ 42 years old; n = 12 from 12 different patients).
Blastocysts were identified by PGT-A to be void of autosomal
chromosomal aneuploidies and were warmed following pre-
viously published vitrification protocols [24]. All fathers were
≤ 48 years of age and therefore not considered to be advanced
paternal age.
RNA isolation
RNA was isolated from individual blastocysts using the
PicoPure™ RNA Isolation Kit (Applied Biosystems, Foster
City, CA) with minor modifications to the manufacturer’s
protocol. Briefly, blastocysts were lysed at 42 °C for 30 min
in 10 μl of extraction buffer. One volume of 70% EtOH was
mixed with each sample prior to loading onto a pre-
conditioned purification column. Each sample was on-
column deoxyribonuclease treated at room temperature for
15 min (Qiagen, Germantown, MD). After several washes,
RNAwas eluted in 20 μl of elution buffer.
RNA sequencing and bioinformatic analysis
The entirety of the purified RNA from each blastocyst (n = 12,
6 from each group) was utilized to prepare sequencing librar-
ies using the SMARTer® Ultra® Low Kit (Clontech
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Laboratories, Fremont, CA) following manufacturer’s instruc-
tions and then sequenced on the HiSEQ 4000 (Illumina, San
Diego, CA) as single pass 50 bp reads. Derived sequences
were processed by performing quality checks and normaliza-
tion on each read and then mapping them to the human ge-
nome (build GRCh38) using Trimmomatic v0.36 [25],
GMAP-GSNAP v2014-12-17 [26], SAMtools v1.5 [27], and
Cufflinks v2.2.1 [28]. Transcripts with no reads across all
samples, as well as transcripts in the bottom quintile based
on mean expression across all samples, were excluded from
analysis. A log transformation was performed prior to statis-
tical analysis which included a 2-sample, 2-sided, independent
Student’s t test (significance at Q < 0.05). The false discovery
rate was then adjusted using the Benjamini-Hochberg proce-
dure and the expression log ratio was used for each differen-
tially expressed transcript. Pathway analysis was performed
on differentially expressed transcripts using Ingenuity
Pathway Analysis (Qiagen). The density of gene start site
positions was quantified by performing a kernel density esti-
mation (KDE) for each chromosome using the distplot func-
tion from the Seaborn v0.8.1 package for Python (www.
python.org). Bandwidth for the KDE was set manually for
chromosome 20 and scaled linearly for all other
chromosomes based on chromosome length. To determine
whether the KDE for the differentially expressed transcripts
was a common occurrence, a 95% percentile interval was
constructed. A total of 2699 gene start sites were randomly
selected (11 of which were start sites for identical genes) and a
KDEwas performed. This process was repeated 1000 times to
obtain 1000 distributions. For each point where the KDE was
calculated, values were obtained for the 97.5th percentile and
the 2.5th percentile. These values were then used to construct
an interval that would contain 95% of the randomly generated
distributions.
Sequencing validation and analysis
Sequencing validation on genes of interest was completed
with isolated RNA from additional blastocysts (n = 12, 6 from
each group). Reverse transcription was performed using the
High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and cDNA was diluted (1:4) in 1X Tris-EDTA
buffer prior to performing quantitative reverse transcription
PCR (RT-qPCR) on the QuantStudio 5 Real-Time PCR
System (Applied Biosystems). Three microliters of diluted
cDNA was combined with 5 μM primer mix and Power
SYBR™ Green PCR Master Mix (Applied Biosystems) in a
15 μl final volume and amplified under the following thermal
cycling conditions: 95 °C for 10 min followed by 40 cycles at
95 °C for 15 s and 60 °C for 1 min, and a melt curve stage at
95 °C for 15 s, 60 °C for 1 min, and 95 °C for 15 s. Each
sample was run in duplicate for 11 genes of interest (ALK,
TNFRSF10A, TSPAN9, CCND3, GNAS, LTBP3,
MAPK8IP1, NDRG1, SREBF1, EPSTI1, TLE2) and ana-
lyzed compared to the expression of three, stable, housekeep-
ing genes (GAPDH, PPIA, RPL19). Statistical analysis was
performed using REST 2009 software (Qiagen) which uses
PCR efficiencies and mean crossing point deviation between
the sample and control groups to test for significance by a Pair
Wise Fixed Reallocation Randomisation Test© (significance
at P < 0.05) [29]. The most consistent housekeeping gene was
selected for normalization (PPIA).
Ethical approval
All participants provided written informed consent and this
study was approved by the Western Institutional Review
Board (protocol no. 20140458).
Results
RNA sequencing
RNA sequencing data was collected and an average of 46.9
million reads were acquired for each blastocyst. Quality filters
were applied to all samples to remove reads with poor se-
quencing quality resulting in 91% of the reads passing these
filters and proceeding for alignment to the human reference
genome (Supplementary Table 1). One sample from the DC
group was eliminated from further analysis due to poor qual-
ity. Expression intensity was calculated using RPKM method
and only transcripts with a mean expression of 0.05 or greater
were considered for analysis, resulting in 26,489 Ensembl IDs
expressed between the two sample sets. A FDR adjusted p
value was used to determine significance and reduce false
positives. Additional quality control was performed to identify
and remove any outliers and overly abundant transcripts to
reduce normalization artifact. In total, 2688 (10%) of the
expressed transcripts were considered significantly differen-
tially transcribed in AMA blastocysts compared to DC with
2551 of these having decreased expression (95%) and 137
displaying increased transcription (5%) (Supplementary
Table 2; Q < 0.05). When considering all transcripts analyzed
(including those that were non-significant), 70% displayed
decreased expression in the AMA sample set, revealing an
overall global decrease in transcription in the blastocysts from
this group. Volcano plot analysis depicts this trend with the
vast majority of significantly differentially expressed tran-
scripts having a negative fold change in AMA blastocysts
(Fig. 1).
Principle component analysis (PCA) was performed to
reveal global differences between the sample groups. Two
distinct sets were identified using PCA, with the AMA
blastocysts grouping together but separately from the
grouped DC blastocysts, indicating uniformity and low
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biological variability among samples within each group
(Fig. 2). Unsupervised hierarchical clustering analysis al-
so distinguished the two groups, with each having unique-
ly different transcription patterns and branching separately
(Fig. 3). The uniformity observed in the AMA blastocyst
transcriptome reflects a strong phenotype for this sample
group. Examination of the gene density on individual
chromosomes revealed a significantly higher number (>
30%; Q < 0.05) of differentially expressed transcripts lo-
calized at the telomeric regions for 9 chromosomes (4, 9,
11, 16, 17, 19, 20, 21, 22) (Supplementary Figure 1).
Over a quarter (28%) of the differentially expressed tran-
scripts in this study were found within 10 Mb of the
telomeric regions at both chromosome ends.
Canonical pathway analysis (IPA®) of the 2688 signif-
icantly altered transcripts revealed hits for G protein–
coupled receptor signaling, calcium signaling, AMPK sig-
naling, and gap junction signaling, among others
(Table 1). Expanded pathway analysis of these statistically
significant transcripts revealed a set of interacting molec-
ular signaling networks and upstream regulators important
for embryo development which included SP1, ESR1,
HDAC1, DMNT3B, TP53, MAPK3, VEGFA, and
CREBBP (Fig. 4). A Regulator Effects analytic (IPA®)
was performed to identify the top 5 upstream regulators
driving the observed global decreased transcription in
AMA blastocysts. Altered pathways that are predicted to
work with other molecules and lead to changes in down-
stream RNA expression included pathways involved in
invasion, transmission and activation of cells, cell move-
ment, and organismal death in blastocysts from women of
advanced maternal age (Supplementary Figure 2).
Sequencing validation
Genes chosen for validation utilizing RT-qPCR focused on the
transcription ligand-dependent activation of ESR1/SP/
CREBBP pathway as it was observed to be a highly signifi-
cant upstream regulator important for a variety of biological
processes including cell cycle regulation, proliferation, and
apoptosis. In total, 62 genes regulated by the ESR1 network
were found to be significantly decreased in AMA blastocysts,
as well as 56 genes regulated by SP1, and 41 genes regulated
by CREBBP (P < 0.05). ESR1-regulated genes chosen for
validation included ALK, TNFRSF10A, and TSPAN9. SP1-
regulated genes examined for validation were CCND3,
GNAS, LTBP3, MAPK8IP1, NDRG1, and SREBF1.
Finally, CREBBP-regulated genes tested included EPSTI1
and TLE2. All genes displayed a trend towards reduced ex-
pression in additional AMA blastocysts tested by RT-qPCR,
compared to DC, confirming our observations from the RNA
sequencing analysis (Fig. 5). TNFRSF10A and TSPAN9,
which are regulated by ESR1, were significantly reduced in
the blastocysts from older women (fold change = 0.63 and
0.23 respectively; P < 0.05; Fig. 5). MAPK8IP1 which is reg-
ulated by SP1 was also significantly reduced in AMA blasto-
cysts (fold change = 0.17; P < 0.05; Fig. 5). EPSTI1, regulated
by CREBBP, was the final gene that displayed a significant
reduction in gene expression among the AMA group (fold


































Fig. 2 Principle component analysis (PCA) depicting a clear separation
of AMA blastocysts from donor controls (DC)
Fig. 1 Differentially expressed transcripts in AMA blastocysts compared
to donor control (DC). The y-axis corresponds to the mean expression
value of Log10 (Q-value) and the x-axis displays the Log2 (fold change)
value. Red dots represent transcripts with statistically significant negative
fold changes in AMA blastocysts (Q < 0.05), whereas the green dots
represent transcripts with statistically significant positive fold changes
in AMA blastocysts (Q < 0.05). Black dots denote genes that were not
significantly altered
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Discussion
Transcriptome analysis of blastocysts from women of ad-
vanced maternal age revealed a significant, global downregu-
lation of gene expression. This altered transcriptome could
compromise future embryonic developmental competence,
explaining the decreased implantation and live birth rates ob-
served in this patient population, following a euploid embryo
transfer.
The ESR1/SP1/CREBBP pathway was predicted as a high-
ly significant upstream regulator driving the observed wide-
spread downregulation in embryonic gene transcription asso-
ciated with AMA. ESR1 is a ligand-activated transcription
factor that can stimulate transcription directly or by activation
of other transcription factors in a ligand-dependent manner
[30]. For ESR1 to function, it requires the recruitment of
coactivators such as SP1 which, in turn, recruit secondary
coactivators including CREBBP that promote chromatin re-
modeling and facilitate the activation of transcription [31, 32].
Cancer studies have shown that when ESR1 is under-
expressed, it fails to activate SP1, resulting in decreased ex-
pression of downstream genes that regulate a variety of pro-
cesses including cell cycle regulation, proliferation, and apo-
ptosis [31]. Furthermore, CREBBP has been previously
shown to be essential for mouse embryogenesis [33].
The ESR1-regulated gene TNFRSF10A that displayed re-
duced expression with advanced maternal age has been impli-
cated in the process of cellular apoptosis. Programmed cell
Fig. 3 Unsupervised hierarchical clustering of differentially expressed
transcripts in AMA blastocysts vs. donor control (DC) showing a distinct
separation between the two groups. Red denotes upregulation while
purple (change from purple to blue if new attachement is used) represents
downregulation (Q < 0.05)
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Table 1 Key canonical pathways that are predicted to be altered in AMA blastocysts vs. donor control (DC) blastocysts (P < 0.05)
Ingenuity canonical
pathways
p value Importance Molecules
G protein–coupled receptor
(GPCR) signaling











Gαi signaling 1.05E-06 Inhibits the production






cAMP-mediated signaling 2.34E-06 GPCR-triggered signaling





















Calcium signaling 3.80E-04 Increase in cytosolic Ca2+
culminates in the regulation
of transcription factors including
NFAT, CREB, and HDACs.
Ca2+ signaling is associated








AMPK signaling 4.47E-04 Inhibits key enzymes of ATP consuming
pathways and induces pathways


































Th1 pathway 9.12E-04 Th1:Th2 balance plays an important
role in successful pregnancy
maintenance and is associated
with a decline in responsiveness
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death plays an important role in gamete maturation and em-
bryo development. Both the inner cell mass and the
trophectoderm have active apoptotic pathways that are re-
quired for ongoing, successful development. Disruptions to
the apoptotic pathway can compromise future growth and
result in reproductive failure [34]. TSPAN9, another de-
creased ESR1-regulated gene in AMA blastocysts, plays a
role in the regulation of cell development, activation, growth,
and motility. Earlier studies have shown that TSPAN9 is lo-
calized to the plasma membrane and cytoplasm, and could be
required for maintaining the early endosome membrane [35].
The endosome functions as a signaling center for various
ligand-receptor systems that have critical roles in embryonic
patterning, particularly in the peri-gastrulation stage of em-
bryo development [36]. Since gastrulation occurs shortly after
implantation, any signaling errors in the embryo during this
critical time would likely negatively impact reproductive suc-
cess. A previous study utilizing C. elegans found that a num-
ber of tetraspanins, including TSP-21 (orthologous to human
TSPAN9), promote BMP signaling in postembryonic devel-
opment [37]. BMP has been shown to be important for pre-
implantation development and gastrulation in mouse embryos
[38]. Both BMP1 and BMP7 were observed in this study to be
significantly reduced in expression with advanced maternal
age. BMP1 has also been shown to promote oocytematuration
and early embryo development in porcine embryos that were
fertilized in vitro [39]. Several studies have displayed the im-
portance of BMP7 for not only the transformation of the en-
dometrium into a receptive state, but also for decidualization,
and placental/embryonic development [40–42].
The SP1-regulated gene, MAPK8IP1, was also significant-
ly reduced in blastocysts derived from AMA women. This
protein prevents MAPK8-mediated activation of transcription
factors and plays a key role in cell signaling. It is also involved
in the JNK signaling pathway and alterations can induce
changes to cellular physiology, including cell death [43].
The JNK pathway has been previously reported to be required
for the 8–16 cell stage of embryonic development to the blas-
tocyst stage [44]. Additionally, Thompson et al. found that
targeted disruption ofMapk8ip1 in themouse embryo resulted
in embryonic death prior to blastocyst implantation [45].
The CREBBP-regulated gene, EPSTI1, is known to pro-
mote tumor invasion and metastasis. While widely known for
its role in invasive breast carcinomas, this gene has also been
found to be crucial in endometrial remodeling prior to embryo
attachment [46]. The trophoblast cells of an early embryo
rapidly proliferate and attempt to invade the endometrial de-
cidua, later proliferating and migrating into the uterine wall to
Fig. 4 Molecular signaling network predicted to be associated with the
global decrease in transcription observed in AMA blastocysts compared
to donor control (DC) blastocysts
Fig. 5 RT-qPCRvalidation of genes within the ESR1/SP1/CREBBPmolecular signaling network that displayed reduced expression in AMA blastocysts
vs. donor control (DC) blastocysts (*P < 0.05)
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anchor the placenta [47]. These actions are extraordinarily
similar to cancer cells with their capacity for proliferation
and migration [47]. The reduced expression observed in
EPSTI1 with advanced maternal age is therefore likely to
not only reduce the ability of the pre-implantation embryo to
proliferate and invade the endometrium, but also hinder the
molecular cross-talk at the fetal-maternal interface, thereby
preventing implantation.
The overall global decrease in transcription observed in
AMA blastocysts also impacted chromatin structure with
two histone deacetylase genes shown to have reduced tran-
scription (HDAC3 and HDAC6). The HDAC family plays a
critical role in development by modulating chromatin struc-
ture involved in DNA replication, repair, and gene transcrip-
tion [48]. Reduced expression would lead to chromatin relax-
ation which can promote DNA damage and result in genomic
instability [49]. Hdac3 is a key regulator of chromatin struc-
ture and inactivation triggers apoptosis in mice [50].
Additionally, Montgomery et al. found that mutant mice with
a global deletion of Hdac3 resulted in early embryo lethality
[51]. Hdac6 has been previously reported to be localized in the
cytoplasm of germinal vesicle stage oocytes and 1-cell embry-
os in mice and its ectopic expression causes premature com-
paction of chromatin [52].
Telomeres are specialized non-coding DNA sequences lo-
cated at the ends of all chromosomes that protect these regions
from recombination and degradation activities as well as serve
to maintain chromosome integrity [53, 54]. Telomeres shorten
as a function of aging due to decreased telomerase activity
leading to DNA damage that causes replicative senescence
[55]. Telomerase activity is absent in most adult human tissues
due to the lack of expression of TERT that is expressed in
developing embryos [56, 57]. TERT expression was signifi-
cantly reduced in the blastocysts from AMA women in our
study, indicating reduced telomerase activity and possibly a
shortening of the telomeres in this aged patient population.
Telomere shortening has been shown to cause widespread
changes in the transcription of genes located up to 10Mb from
a telomere in human myoblasts which could explain the high
proportion of significant differentially expressed genes locat-
ed in the sub-telomeric regions of AMA blastocysts [55].
Similarities were observed between our study and the pub-
lication by Kawai et al. who investigated gene expression
profiles in human blastocysts relative to parental age (31–
41 years of age) [23]. Several, common, downregulated genes
were involved in cell growth, differentiation, and proliferation
including PCBP4, PPP2R2C, MYO16, and PTPRD. Others
were linked to oxidative damage, cell stress, and the inflam-
matory response which included MSRA, FAAP24, MICU1,
and AOAH. TLE6 was also downregulated in both studies
and has additionally been reported to be reduced in the
trophectoderm cells from non-implanting embryos [58].
These similarities reinforce our findings that blastocysts from
women of advanced maternal age are being impacted on a cell
signaling level to repress the embryo’s ability to proliferate
and implant.
To our knowledge, this is the first study utilizing total RNA
sequencing technology to examine, specifically, the impact of
advanced maternal age (≥ 42 years) on pre-implantation em-
bryonic development directly compared to young, donor con-
trols, highlighting the molecular changes occurring in the
AMA patient. An overall compromised global transcriptome
was observed in maternally aged blastocysts impacting tran-
scriptional regulators and their biological pathways including
cell growth, invasion, and an increased probability for organ-
ismal death, among others. These results provide molecular
evidence of compromised embryo development with ad-
vancedmaternal age, explaining the deterioration of reproduc-
tive outcomes for this patient population, independent of chro-
mosome constitution.
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